Buy Karyopharm Therapeutics Stock | KPTI Stock Price & Latest News | Public
KPTI

Karyopharm Therapeutics

$0.00 (0.00%)Today

    About KPTI

    Karyopharm Therapeutics, Inc. is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major disea...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.26
    -0.52
    -0.78
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.60

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,11B
    Volume20,11k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$29.61
    1 Year Low$13.39
    Open$15.90
    High$15.95
    Low$15.09

    Buy any stock with any amount of money.

    Download the App
    Download the app